SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Maurizio Clementi, Corinna Weber-Schöndorfer, Drugs During Pregnancy and Lactation, 2015,

    CrossRef

  2. 2
    Kirsten Lawrence Cleary, Kelly Roney, Maged Costantine, Challenges of studying drugs in pregnancy for off-label indications: Pravastatin for preeclampsia prevention, Seminars in Perinatology, 2014, 38, 8, 523

    CrossRef

  3. 3
    Alexander M. Friedman, Kirsten L. Cleary, Prediction and prevention of ischemic placental disease, Seminars in Perinatology, 2014, 38, 3, 177

    CrossRef

  4. 4
    Marleen M.H.J. van Gelder, Iris A.L.M. van Rooij, Lolkje T.W. de Jong-van den Berg, Nel Roeleveld, Teratogenic Mechanisms Associated with Prenatal Medication Exposure, Thérapie, 2014, 69, 1, 13

    CrossRef

  5. 5
    R. N. Spencer, D. J. Carr, A. L. David, Treatment of poor placentation and the prevention of associated adverse outcomes – what does the future hold?, Prenatal Diagnosis, 2014, 34, 7
  6. 6
    Judith Zarek, Kaitlyn E Delano, Cheri Nickel, Carl A Laskin, Gideon Koren, Are statins teratogenic in humans? Addressing the safety of statins in light of potential benefits during pregnancy, Expert Review of Obstetrics & Gynecology, 2013, 8, 6, 513

    CrossRef

  7. 7
    U Winterfeld, A Allignol, A Panchaud, LE Rothuizen, P Merlob, B Cuppers-Maarschalkerweerd, T Vial, S Stephens, M Clementi, M Santis, A Pistelli, M Berlin, G Eleftheriou, E Maňáková, T Buclin, Pregnancy outcome following maternal exposure to statins: a multicentre prospective study, BJOG: An International Journal of Obstetrics & Gynaecology, 2013, 120, 4
  8. 8
    Suzanna Morton, Shakila Thangaratinam, Statins in pregnancy, Current Opinion in Obstetrics and Gynecology, 2013, 25, 6, 433

    CrossRef

  9. 9
    E. Bismuth, C. Bouche, C. Caliman, J. Lepercq, V. Lubin, D. Rouge, J. Timsit, A. Vambergue, Management of pregnancy in women with type 1 diabetes mellitus: Guidelines of the French-Speaking Diabetes Society (Société francophone du diabète [SFD]), Diabetes & Metabolism, 2012, 38, 3, 205

    CrossRef

  10. 10
    J. Kramer, M. Bartsch, D. Krug, M. Klinger, M. Nitschke, J. Rohwedel, Simvastatin modulates mouse embryonic stem cell-derived chondrogenesis in vitro, Toxicology in Vitro, 2012, 26, 7, 1170

    CrossRef

  11. 11
    D Meeike Kusters, Hajar Hassani Lahsinoui, Joris AM van de Post, Albert Wiegman, Frits A Wijburg, John JP Kastelein, Barbara A Hutten, Statin use during pregnancy: a systematic review and meta-analysis, Expert Review of Cardiovascular Therapy, 2012, 10, 3, 363

    CrossRef

  12. 12
    Edouard Lecarpentier, Olivier Morel, Thierry Fournier, Elisabeth Elefant, Pascale Chavatte-Palmer, Vassilis Tsatsaris, Statins and Pregnancy, Drugs, 2012, 72, 6, 773

    CrossRef

  13. 13
    Arzneimittel in Schwangerschaft und Stillzeit, 2012,

    CrossRef

  14. 14
    Lewis B. Holmes, Human teratogens: Update 2010, Birth Defects Research Part A: Clinical and Molecular Teratology, 2011, 91, 1
  15. 15
    Clara Bouché, Elise Bismuth, Catherine Caliman, Jacques Lepercq, Vanessa Lubin, Delphine Rougé, José Timsit, Anne Vambergue, Prise en charge de la grossesse au cours du diabète de type 1, Médecine des Maladies Métaboliques, 2011, 5, 1, 91

    CrossRef

  16. 16
    Clara Bouché, Elise Bismuth, Catherine Caliman, Jacques Lepercq, Vanessa Lubin, Delphine Rougé, José Timsit, Anne Vambergue, Prise en charge de la grossesse au cours du diabète de type 1, Médecine des Maladies Métaboliques, 2011, 5, 1, 7

    CrossRef

  17. 17
    Ángel Brea Hernando, Tratamiento de la dislipemia en grupos especiales: ancianos y embarazadas, Clínica e Investigación en Arteriosclerosis, 2011, 23, 1, 31

    CrossRef

  18. 18
    Dorothea Haas, Maximilian Muenke, Abnormal sterol metabolism in holoprosencephaly, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2010, 154C, 1
  19. 19
    Candice Y. Johnson, Sonja A. Rasmussen, Non-genetic risk factors for holoprosencephaly, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2010, 154C, 1
  20. 20
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2009, 18, 1
  21. 21
    B. Giannakopoulos, S. A. Krilis, How I treat the antiphospholipid syndrome, Blood, 2009, 114, 10, 2020

    CrossRef

  22. 22
    Hans J Avis, Barbara A Hutten, Marcel ThB Twickler, John JP Kastelein, Joris AM van der Post, Anton F Stalenhoef, Maud N Vissers, Pregnancy in women suffering from familial hypercholesterolemia: a harmful period for both mother and newborn?, Current Opinion in Lipidology, 2009, 20, 6, 484

    CrossRef